一项在中国健康成年男性志愿者中进行的K-877的单中心、开放性、多剂量、平行分组的药代动力学研究
[Translation] A single-center, open-label, multiple-dose, parallel-group pharmacokinetic study of K-877 in healthy adult male volunteers from China
本研究的目的旨在中国健康成年男性中评估K-877(pemafibrate)及其代谢物的药代动力学(PK)。
[Translation] The aim of this study was to evaluate the pharmacokinetics (PK) of K-877 (pemafibrate) and its metabolites in healthy Chinese adult males.
100 Clinical Results associated with Xinghe Co., Ltd
0 Patents (Medical) associated with Xinghe Co., Ltd
100 Deals associated with Xinghe Co., Ltd
100 Translational Medicine associated with Xinghe Co., Ltd